Damora Therapeutics, Inc. (DMRA) stock
DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$22.56+0.06 (+0.29%)
Close on Nov 17, 2026Market cap $1.39BP/E 5.7Yield 0.00%
Damora Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Damora Therapeutics's price to book ratio was 2.8× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.2× to 5.2×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.8× | −1.8 |
| 2025 | Dec 31, 2025 | 4.6× | +4.3 |
| 2024 | Dec 31, 2024 | 0.3× | −0.2 |
| 2023 | Dec 29, 2023 | 0.5× | +0.1 |
| 2022 | Dec 30, 2022 | 0.4× | −0.2 |
| 2021 | Dec 31, 2021 | 0.6× | – |
See a number that looks wrong?